Status:
COMPLETED
Chromium and Insulin Resistance
Lead Sponsor:
University of California, San Francisco
Conditions:
Insulin Resistance
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
Chromium is an essential nutrient for the maintenance of normal glucose tolerance and its deficiency causes insulin resistance. Chromium administration has also been shown in several studies to lower ...
Detailed Description
Chromium is an essential nutrient for the maintenance of normal glucose tolerance and its deficiency causes insulin resistance. Chromium administration has also been shown in several studies to lower ...
Eligibility Criteria
Inclusion
- Not exercising regularly, healthy, non-diabetic.
Exclusion
- Diabetes, heart disease, hepatitis, HIV, impaired glucose tolerance, abnormal liver enzymes, abnormal TSH levels, other abnormal lab values.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00846248
Start Date
January 1 2006
End Date
July 1 2011
Last Update
August 31 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF
San Francisco, California, United States, 94143